Expression of Ces1 was induced during 3T3-L1 adipocyte differentiation [33], and administration of Ces1 inhibitors to HFD fed mice or db/db mice protected from weight gain reduced plasma lipids, ameliorated liver steatosis, and improved glucose tolerance [34]. The gene discussed is CES1; the disease is fatty liver disease.